Company Filing History:
Years Active: 2020-2023
Title: Innovations by Kari L Cierzan
Introduction
Kari L Cierzan is an accomplished inventor based in Minnetonka, MN (US). She has made significant contributions to the field of medical devices, particularly in the area of bladder treatment technologies. With a total of three patents to her name, Cierzan's work focuses on innovative solutions for urinary tract disorders.
Latest Patents
Cierzan's latest patents include a micro-needle bladder balloon designed for delivering treatment fluids or particulates, such as stem cells and drugs, directly to the inner lining of the bladder. This device aims to address urinary tract disorders, including over-active bladder. The balloon delivery system features an inflation balloon equipped with multiple micro-needles that can pierce the inner bladder wall, allowing for direct injection of treatment fluids into the bladder tissue. Additionally, the micro-needles can be made from bioabsorbable materials, enabling them to remain embedded in the bladder tissue for ongoing treatment delivery. Another notable patent involves a fluid delivery system that consists of a first balloon and a second balloon, with the second balloon containing micro-needles that facilitate fluid delivery to tissue.
Career Highlights
Cierzan is currently employed at Boston Scientific Scimed, Inc., where she continues to develop innovative medical technologies. Her work has garnered attention for its potential to improve patient outcomes in the treatment of bladder-related conditions.
Collaborations
Cierzan collaborates with talented professionals in her field, including Carrie Lee Herman and Natalie Ann Borgos. These partnerships enhance the development and implementation of her innovative ideas.
Conclusion
Kari L Cierzan's contributions to medical device innovation, particularly in bladder treatment technologies, highlight her role as a leading inventor in her field. Her patents reflect a commitment to improving healthcare solutions for urinary tract disorders.